These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

87 related articles for article (PubMed ID: 23350442)

  • 1. [Identification of a novel serum marker for early breast cancer detection by proteomic approach].
    Kadowaki M; Nagashima T; Sakakibara M; Suzuki TH; Miyazaki M
    Nihon Rinsho; 2012 Sep; 70 Suppl 7():460-3. PubMed ID: 23350442
    [No Abstract]   [Full Text] [Related]  

  • 2. High-throughput genomic technology in research and clinical management of breast cancer. Plasma-based proteomics in early detection and therapy.
    Davis MA; Hanash S
    Breast Cancer Res; 2006; 8(6):217. PubMed ID: 17184556
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Clinical significance of serum proteomic patterns in diagnosis of breast cancer].
    Liu DH; Zhang LM; Feng WY
    Zhonghua Zhong Liu Za Zhi; 2006 Oct; 28(10):770-1. PubMed ID: 17366791
    [No Abstract]   [Full Text] [Related]  

  • 4. The evolving role of proteomics in the early detection of breast cancer.
    Pawlik TM; Kuerer HM
    Int J Fertil Womens Med; 2005; 50(5 Pt 1):212-6. PubMed ID: 16468471
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Identification of serum protein markers for breast cancer relapse with SELDI-TOF MS.
    Lei L; Wang XJ; Zheng ZG; Huang J; Cao WM; Chen ZH; Shao XY; Cai JF; Ye WW; Lu HY
    Anat Rec (Hoboken); 2011 Jun; 294(6):941-4. PubMed ID: 21548109
    [TBL] [Abstract][Full Text] [Related]  

  • 6. MALDI-TOF serum protein profiling for the detection of breast cancer.
    de Noo ME; Deelder A; van der Werff M; Ozalp A; Mertens B; Tollenaar R
    Onkologie; 2006 Nov; 29(11):501-6. PubMed ID: 17068384
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Application of serum proteomics in breast cancer research].
    Zhu ZM; Hu XF; Zeng R
    Zhonghua Zhong Liu Za Zhi; 2007 Aug; 29(8):561-5. PubMed ID: 18210871
    [No Abstract]   [Full Text] [Related]  

  • 8. [Proteic profiling SELDI-TOF and breast cancer: clinical potential applications].
    Gonçalves A; Bertucci F; Birnbaum D; Borg JP
    Med Sci (Paris); 2007 Mar; 23 Spec No 1():23-6. PubMed ID: 17669349
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Breast cancer screening and biomarkers.
    Brooks M
    Methods Mol Biol; 2009; 472():307-21. PubMed ID: 19107439
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Use of serological proteomic methods to find biomarkers associated with breast cancer.
    Rui Z; Jian-Guo J; Yuan-Peng T; Hai P; Bing-Gen R
    Proteomics; 2003 Apr; 3(4):433-9. PubMed ID: 12687611
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Diagnostic application of serum protein pattern and artificial neural network software in breast cancer].
    Hu Y; Zhang SZ; Yu JK; Liu J; Zheng S; Hu X
    Ai Zheng; 2005 Jan; 24(1):67-71. PubMed ID: 15642203
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Biomarker discovery using a comparative omics approach in a mouse model developing heterogeneous mammary cancer subtypes.
    Pennings JL; Van Dycke KC; van Oostrom CT; Kuiper RV; Rodenburg W; de Vries A
    Proteomics; 2012 Jul; 12(13):2149-57. PubMed ID: 22807454
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Proteomics success story. Towards early detection of breast and ovarian cancer: plasma proteomics as a tool to find novel markers.
    Souchelnytskyi S; Lomnytska M; Dubrovska A; Hellman U; Volodko N
    Proteomics; 2006 Sep; 6 Suppl 2():65-8. PubMed ID: 17031801
    [No Abstract]   [Full Text] [Related]  

  • 14. [Application of serum proteomic mass spectrum analysis in breast cancer].
    Ying MG; Chen Q; Ye YB; Chen HJ; Chen X; Zheng HY; Wu F
    Zhonghua Zhong Liu Za Zhi; 2010 Sep; 32(9):698-702. PubMed ID: 21122387
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical application of proteomics in breast cancer: state of the art and perspectives.
    Goncalves A; Bertucci F
    Med Princ Pract; 2011; 20(1):4-18. PubMed ID: 21160207
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Serum degradome markers for the detection of breast cancer.
    van Winden AW; van den Broek I; Gast MC; Engwegen JY; Sparidans RW; van Dulken EJ; Depla AC; Cats A; Schellens JH; Peeters PH; Beijnen JH; van Gils CH
    J Proteome Res; 2010 Aug; 9(8):3781-8. PubMed ID: 20557135
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Autoantibody to tumor antigen, alpha 2-HS glycoprotein: a novel biomarker of breast cancer screening and diagnosis.
    Yi JK; Chang JW; Han W; Lee JW; Ko E; Kim DH; Bae JY; Yu J; Lee C; Yu MH; Noh DY
    Cancer Epidemiol Biomarkers Prev; 2009 May; 18(5):1357-64. PubMed ID: 19423516
    [TBL] [Abstract][Full Text] [Related]  

  • 18. SELDI-TOF serum proteomics and breast cancer: which perspective?
    Garrisi VM; Abbate I; Quaranta M; Mangia A; Tommasi S; Paradiso A
    Expert Rev Proteomics; 2008 Dec; 5(6):779-85. PubMed ID: 19086858
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Proteomics: new technologies and clinical applications.
    Latterich M; Abramovitz M; Leyland-Jones B
    Eur J Cancer; 2008 Dec; 44(18):2737-41. PubMed ID: 18977654
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Identification of mammaglobin as a novel serum marker for breast cancer.
    Bernstein JL; Godbold JH; Raptis G; Watson MA; Levinson B; Aaronson SA; Fleming TP
    Clin Cancer Res; 2005 Sep; 11(18):6528-35. PubMed ID: 16166429
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.